STAAR SURGICAL CO

For the period ended Jan 2, 2026. Filed Mar 3, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Mar 3, 2026

STAA$24.55-2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page

PART I

Item 1. Business (no text here)

ITEM 1. Business

Item 1A. Risk Factors (no text here)

ITEM 1A. Risk Factors

Item 1B. Unresolved Staff Comments (no text here)

ITEM 1B. Unresolved Staff Comments

Item 1C. Cybersecurity (no text here)

ITEM 1C. Cybersecurity

Item 2. Properties (no text here)

ITEM 2. Properties

Item 3. Legal Proceedings (no text here)

ITEM 3. Legal Proceedings

Item 4. Mine Safety Disclosures (no text here)

ITEM 4. Mine Safety Disclosures

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities (no text here)

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities Unregistered Sales of Equity Securities and Use of Proceeds

Item 6. [Reserved] (no text here)

ITEM 6. [Reserved] (no text here)

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations (no text here)

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7A. Quantitative and Qualitative Disclosures About Market Risk (no text here)

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk ITEM 8. Financial Statements and Supplementary Data

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure (no text here)

ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9A. Controls and Procedures (no text here)

ITEM 9A. Controls and Procedures

Item 9B. Other Information (no text here)

ITEM 9B. Other Information

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections (no text here)

ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

PART III

PART III Item 10. Directors, Executive Officers, and Corporate Governance Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Item 13. Certain Relationships and Related Transactions, and Director Independence Item 14. Principal Accounting Fees and Services

PART IV

Item 15. Exhibits and Financial Statement Schedules (no text here)

ITEM 15. Exhibits and Financial Statement Schedules

Item 16. Form 10-K Summary (no text here)

ITEM 16. Form 10-K Summary SIGNATURES Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets Consolidated Statements of Operations Consolidated Statements of Comprehensive Income (Loss)Consolidated Statements of Stockholders’ Equity Item 8. Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements II. Schedule II — Valuation and Qualifying Accounts and Reserves

ITEM 9B. Other Information

(c)

Trading Plans

During the quarter ended January 2, 2026, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act)adopted orterminated:

(i)

Any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c); and

(ii)

Any “non-Rule 10b5-1 trading arrangement” as defined in paragraph (c) of item 408(a) of Regulation S-K.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.